Aarti Drugs

340.20
-13.85
(-3.91%)
ann
There are new updates from the company21 hours ago
Viewcross
right
Market Cap
3,105.01 Cr
EPS
18.56
PE Ratio
21.31
Dividend Yield
0.28 %
Industry
Healthcare
52 Week High
635.00
52 Week low
332.60
PB Ratio
2.55
Debt to Equity
0.47
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
SEBI Issues Administrative Warning Letter to Aarti Drugs5 days ago
Aarti Drugs has received an administrative warning letter from the Securities and Exchange Board of India (SEBI). The details of the warning or the specific reasons for it are not provided in the given news snippet.
neutral
SEBI Issues Administrative Warning to Aarti Drugs' Compliance Officer and Company Secretary5 days ago
The Securities and Exchange Board of India (SEBI) has issued an administrative warning to Aarti Drugs Limited's Compliance Officer and Company Secretary. The company has stated that this warning will not impact its financial, operational, or other activities.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,676.85 4,02,332.48 33.68 49,887.20 12.06 9,648 13.77 51.48
5,667.15 1,50,445.03 71.18 8,184.00 0.89 1,600 64.53 47.74
1,454.30 1,17,451.31 23.41 26,520.70 14.17 4,155 47.38 50.99
3,096.50 1,04,799.63 55.61 10,785.70 11.59 1,656 13.54 51.13
1,105.15 92,214.92 17.35 28,905.40 12.36 5,578 1.69 29.06
1,966.70 89,720.37 31.45 20,141.50 19.94 1,936 38.82 43.35
2,166.45 89,380.56 44.67 10,615.60 19.57 1,942 -16.38 30.70
888.25 89,378.73 19.97 19,831.50 13.82 3,831 29.92 42.12
1,107.90 64,347.01 17.97 29,559.20 17.55 3,169 -10.04 46.41
29,795.85 63,314.10 48.58 6,097.20 10.80 1,201 16.01 51.54
Growth Rate
Revenue Growth
-6.83 %
Net Income Growth
3.12 %
Cash Flow Change
169.22 %
ROE
-4.01 %
ROCE
-6.00 %
EBITDA Margin (Avg.)
11.75 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
283
273
265
314
292
316
291
299
258
319
336
332
375
348
380
464
406
478
474
459
546
578
533
503
582
580
642
697
622
688
665
743
662
642
608
621
557
600
569
Expenses
240
230
226
269
244
265
247
253
223
267
282
274
322
300
328
403
351
409
410
378
411
462
425
421
500
506
545
608
555
614
593
649
577
565
536
534
490
531
495
EBITDA
44
42
40
45
48
51
43
46
36
53
54
57
54
47
52
61
55
69
64
81
135
117
108
82
81
74
97
89
67
74
72
94
85
77
72
87
66
69
74
Operating Profit %
15 %
16 %
15 %
14 %
16 %
16 %
15 %
16 %
14 %
16 %
16 %
17 %
14 %
14 %
14 %
12 %
13 %
14 %
13 %
16 %
25 %
20 %
20 %
16 %
14 %
13 %
14 %
12 %
11 %
11 %
11 %
13 %
13 %
12 %
12 %
14 %
12 %
11 %
11 %
Depreciation
9
9
9
9
10
10
10
9
10
10
10
10
10
11
11
11
12
12
12
13
12
13
13
12
12
13
13
13
13
13
13
13
13
13
13
14
13
14
14
Interest
10
11
11
12
10
9
9
9
9
8
9
9
9
10
11
10
9
9
8
8
7
7
5
4
4
5
5
6
7
9
9
9
9
8
8
9
9
9
9
Profit Before Tax
25
23
23
25
29
33
24
31
17
35
35
38
34
27
31
40
34
48
43
61
116
97
90
65
65
56
79
71
48
53
50
73
64
56
52
64
44
46
51
Tax
8
7
6
6
9
11
6
9
5
11
12
14
10
9
10
12
11
16
15
2
31
22
22
14
16
14
20
15
13
14
13
17
16
17
15
17
11
11
14
Net Profit
17
16
17
19
20
22
18
22
11
24
23
24
23
18
21
27
23
32
28
59
85
75
68
52
49
43
58
55
35
39
37
56
48
40
37
47
33
35
37
EPS in ₹
7.18
6.49
7.03
7.68
8.21
9.11
7.56
8.70
4.77
9.89
9.78
9.97
9.82
7.65
8.86
12.06
9.56
13.87
11.92
25.26
9.17
8.08
7.30
5.54
5.25
4.60
6.29
5.97
3.76
4.18
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
Fixed Assets
449
493
581
602
625
644
665
690
676
811
Current Assets
526
565
571
737
784
900
1,057
1,393
1,492
1,321
Capital Work in Progress
16
34
14
28
33
12
19
77
210
261
Investments
0
0
12
11
12
13
17
20
19
20
Other Assets
537
575
584
748
785
907
1,064
1,422
1,516
1,340
Total Liabilities
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
Current Liabilities
483
501
494
622
591
623
595
940
950
796
Non Current Liabilities
211
244
297
312
321
301
257
232
279
355
Total Equity
308
357
400
455
543
653
913
1,036
1,193
1,282
Reserve & Surplus
284
333
376
432
520
629
820
944
1,100
1,190
Share Capital
24
24
24
24
24
23
93
93
93
92

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-0
0
1
2
2
13
-14
-1
Investing Activities
-107
-99
-107
-74
-62
-33
-72
-150
-164
-224
Operating Activities
105
133
175
70
143
251
155
70
133
359
Financing Activities
2
-33
-68
4
-80
-215
-81
92
17
-136

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
60.20 %
60.14 %
60.12 %
59.99 %
59.83 %
59.98 %
59.77 %
59.66 %
59.58 %
58.70 %
58.56 %
57.47 %
57.13 %
55.67 %
55.64 %
55.38 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.33 %
2.10 %
2.56 %
2.96 %
2.50 %
2.28 %
DIIs
1.59 %
1.97 %
2.09 %
2.28 %
2.69 %
2.76 %
3.16 %
3.90 %
4.09 %
4.71 %
5.32 %
5.26 %
5.99 %
7.35 %
7.84 %
8.77 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.86 %
32.32 %
32.68 %
32.85 %
32.02 %
32.16 %
26.66 %
25.98 %
25.72 %
25.34 %
24.65 %
25.84 %
25.11 %
24.75 %
24.80 %
24.32 %
Others
6.36 %
5.57 %
5.11 %
4.89 %
5.46 %
5.10 %
10.41 %
10.46 %
10.61 %
11.25 %
9.14 %
9.33 %
9.20 %
9.27 %
9.21 %
9.24 %
No of Share Holders
1,73,704
1,77,992
1,83,344
1,95,469
1,89,607
1,86,674
1,80,303
1,73,283
1,69,090
1,62,409
1,67,446
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1 1 2 2.5 1 1 1 0.00
Dividend Yield (%) 0.00 0.79 0.63 0.8 0.29 0.58 0.3 0.23 0.28 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21 hours ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")
5 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") - Action Taken Or Order Passed
5 days ago
Announcement Under Regulation 30 Of Listing Regulations - ESG Rating
8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 28, 2025, 18:25
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 28, 2025, 18:25
Disclosure Under Reg 30 Of Listing Regulations - Update On Lifting Of Import Alert 66-40 By US DFA
Feb 14, 2025, 15:10
Disclosure Under Regulation 30 Of Listing Reguations- Order Of CGST And C.Ex. Authority
Feb 07, 2025, 20:09
Disclosure Under Regulation 30 Of Listing Regulations-
Feb 05, 2025, 21:48
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 04, 2025, 22:25
Announcement under Regulation 30 (LODR)-Acquisition
Feb 04, 2025, 15:04
Announcement under Regulation 30 (LODR)-Acquisition
Feb 03, 2025, 15:37
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 31, 2025, 18:14
Announcement under Regulation 30 (LODR)-Credit Rating
Jan 31, 2025, 13:49
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 30, 2025, 18:41
Announcement under Regulation 30 (LODR)-Investor Presentation
Jan 29, 2025, 21:13
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 29, 2025, 21:09
Announcement under Regulation 30 (LODR)-Acquisition
Jan 29, 2025, 20:43
Integrated Filing (Financial)
Jan 29, 2025, 20:32
Record Date For Interim Dividend
Jan 29, 2025, 17:34
Corporate Action-Board approves Dividend
Jan 29, 2025, 17:32
Board Meeting Outcome for Financial Results And Interim Dividend
Jan 29, 2025, 16:46
Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim Dividend
Jan 29, 2025, 16:41
Disclosure Under Regulation 30 Of Listing Regulations
Jan 28, 2025, 22:16
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 23, 2025, 19:51
Board Meeting Intimation for Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim Dividend If Any.
Jan 22, 2025, 17:38
Announcement under Regulation 30 (LODR)-Acquisition
Jan 09, 2025, 20:44
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 07, 2025, 19:43
Closure of Trading Window
Dec 27, 2024, 18:28
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 15, 2024, 21:56
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 06, 2024, 19:43
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 06, 2024, 19:41
Announcement under Regulation 30 (LODR)-Acquisition
Nov 27, 2024, 23:56
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 27, 2024, 16:52
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 22, 2024, 19:08
Restoration Of Manufacturing Process Of Particular Product At T-150 Unit
Nov 16, 2024, 18:33
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 14, 2024, 19:30
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 13, 2024, 20:00
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 13, 2024, 19:56
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 06, 2024, 17:54
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 06, 2024, 17:50
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 02, 2024, 19:10
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 02, 2024, 19:02
Announcement under Regulation 30 (LODR)-Credit Rating
Oct 30, 2024, 23:21
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 26, 2024, 19:25
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Oct 25, 2024, 19:10
Announcement under Regulation 30 (LODR)-Investor Presentation
Oct 24, 2024, 21:28
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Oct 24, 2024, 21:21
Financial Results For The Quarter And Half Year Ended September 30, 2024
Oct 24, 2024, 18:04
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 18, 2024, 19:40

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
36.77
ATR(14)
Volatile
16.51
STOCH(9,6)
Neutral
55.10
STOCH RSI(14)
Neutral
64.66
MACD(12,26)
Bearish
-0.06
ADX(14)
Weak Trend
15.02
UO(9)
Bearish
57.12
ROC(12)
Downtrend And Accelerating
-8.68
WillR(14)
Neutral
-64.01